Carisma Therapeutics Inc. (CARM)
0.40
-0.00 (-0.25%)
At close: Mar 03, 2025, 3:59 PM
0.42
3.94%
After-hours: Mar 03, 2025, 05:30 PM EST
Carisma Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | 14.92M | 9.83M | 26.54M | 11.24M | n/a | n/a | 425K | 29.98M | 990K | 2.24M | 1.33M | n/a | n/a |
| Cost of Revenue | 74.13M | 6.09M | 85K | n/a | 219K | 208K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | -59.21M | 3.74M | 26.46M | 11.24M | -219K | -208K | 425K | 29.98M | 990K | 2.24M | 1.33M | n/a | n/a |
| Operating Income | -88.73M | -56.16M | -40.79M | -28.38M | -36.87M | -25.7M | -19.98M | 6.17M | -35.2M | -33.78M | -16.63M | -19.49M | -12.68M |
| Interest Income | 1.94M | 1.85M | 10K | 29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -86.88M | -61.23M | -40.78M | -28.35M | -107.5M | -33.69M | -29.03M | 1.9M | -33.45M | -34.16M | -18.02M | -19.66M | -12.83M |
| Net Income | -86.88M | -61.23M | -40.77M | -28.32M | -107.5M | -33.69M | -29.03M | 1.89M | -33.45M | -34.53M | -19.43M | -19.82M | -12.98M |
| Selling & General & Admin | 29.52M | 3.29M | 6.41M | 5.09M | 12.21M | 11.62M | 7.9M | 11.44M | 9.85M | 8.47M | 4.02M | 4.21M | 3.27M |
| Research & Development | 74.13M | 56.62M | 34.39M | 23.29M | 24.44M | 13.87M | 12.22M | 12.2M | 25.97M | 26.7M | 13.79M | 15.26M | 9.41M |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 103.65M | 59.91M | 40.79M | 28.38M | 36.65M | 25.49M | 20.13M | 23.64M | 35.82M | 35.17M | 17.81M | 19.48M | 12.68M |
| Interest Expense | n/a | 3.15M | n/a | n/a | n/a | n/a | n/a | 247K | 1.4M | 376K | 1.4M | 168K | 151K |
| Selling & Marketing Expenses | n/a | 30.41M | n/a | n/a | n/a | n/a | -170K | -3.3M | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 103.65M | 66M | 40.79M | 28.38M | 36.87M | 25.7M | 20.41M | 23.82M | 36.19M | 35.17M | 17.81M | 19.48M | 12.68M |
| Income Tax | n/a | -3.88M | -10K | -29K | n/a | 46.86K | n/a | 5K | 1.4M | 376K | 1.4M | 168K | 151K |
| Shares Outstanding (Basic) | 33.52M | 106.4K | 9.12M | 5.91M | 4.55M | 3.09M | 1.31M | 1.05M | 949.65K | 732.2K | 426.95K | 355.9K | 426.95K |
| Shares Outstanding (Diluted) | 33.52M | 106.4K | 9.12M | 5.91M | 4.55M | 3.09M | 1.31M | 1.09M | 949.65K | 732.2K | 426.95K | 355.9K | 426.95K |
| EPS (Basic) | -2.59 | -575.42 | -4.47 | -4.79 | -23.64 | -10.91 | -22.24 | 1.79 | -35.23 | -47.16 | -45.5 | -55.7 | -30.39 |
| EPS (Diluted) | -2.59 | -575.42 | -4.47 | -4.79 | -23.64 | -10.91 | -22.24 | 1.74 | -35.23 | -47.16 | -45.5 | -55.7 | -30.39 |
| EBITDA | -85.89M | -51.99M | -40.11M | -27.93M | -107.28M | -33.48M | -28.74M | 2.32M | -31.69M | -33.37M | -17.18M | -19.04M | -12.31M |
| Depreciation & Amortization | 2.84M | 6.09M | 85K | 122K | 219K | 208K | 285K | 178K | 366K | 410K | 438K | 448K | 364K |